- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.10. | HHS staffers wait for news after government shutdown | ||
| 30.09. | Trump, Pfizer announce MFN deal; Lilly, others to come | ||
| 30.09. | Data backs Vertanical's cannabis therapy for back pain | ||
| 30.09. | New £1.2bn science park opens in Oxford | ||
| 30.09. | UK says 'online NHS hospital ' will launch in 2027 | ||
| 30.09. | AbbVie joins BMS in taking a hard line on UK drug pricing | ||
| 30.09. | PhRMA unveils DTC sales site, as more drugmakers join in | ||
| 29.09. | Enhertu scores again in early breast cancer | ||
| 29.09. | Enanta weakens on RSV treatment trial readout | ||
| 29.09. | AstraZeneca hops on the DTC sales train in the US | ||
| 29.09. | Genmab agrees $8bn takeover of cancer biotech Merus | ||
| 29.09. | Walmsley to leave GSK in surprise exit | ||
| 26.09. | FDA will review abortion pill safety - will it be impartial? | ||
| 26.09. | BMS adds discounted psoriasis drug to its DTC channel | ||
| 26.09. | Lilly brings second oral SERD to market for breast cancer | ||
| 26.09. | Shock as Trump says 100% pharma tariffs will start on 1 Oct | ||
| 25.09. | Biolinq bags FDA okay for autonomous glucose sensor | ||
| 25.09. | Merck names electronics unit head to replace Garijo as CEO | ||
| 25.09. | Verona Pharma shareholders back $10bn MSD takeover | ||
| 25.09. | AZ takes Medicare negotiation appeal to SCOTUS | ||
| 25.09. | Acadia, Harmony record late-stage rare disease failures | ||
| 25.09. | Moderna opens UK facility as drug pricing spat rumbles on | ||
| 24.09. | Joy as uniQure Huntington's therapy clears pivotal trial | ||
| 24.09. | BMS eyes filings for myeloma 'celmod' iberdomide | ||
| 24.09. | MSD's $345m alliance with Variational, and other AI news |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .